Page 1 of Clinical Trials for Drug Matching placebo to sitagliptin, 43 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)
Last Updated: March 11, 2011
Condition(s): Type 2 Diabetes Mellitus
2
Completed
MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)
Last Updated: September 9, 2011
Condition(s): Type 2 Diabetes Mellitus
3
Completed
A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents (0431-081)
Last Updated: December 21, 2011
Condition(s): Type 2 Diabetes
4
Recruiting
A Study of the Safety and Efficacy of MK-0431A in Pediatric Participants With Type 2 Diabetes Mellitus (MK-0431A-170)
Last Updated: May 10, 2012
Condition(s): Diabetes Mellitus, Type 2
5
Recruiting
A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)
Last Updated: May 10, 2012
Condition(s): Type 2 Diabetes Mellitus
6
Not yet recruiting
A Study to Assess the Pharmacokinetics and the Ability for Pediatric Participants With Type 2 Diabetes to Swallow MK-0431A XR Tablets (MK-0431A-296)
Last Updated: May 22, 2012
Condition(s): Type 2 Diabetes Mellitus
7
Completed
A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics
Last Updated: March 22, 2012
Condition(s): Diabetes Mellitus, Type 2
8
Not yet recruiting
Sitagliptin and HIV
Last Updated: March 12, 2012
Condition(s): Inflammation; Macrophage Infiltration; Cardiovascular Disease
9
Active, not recruiting
A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.
Last Updated: May 3, 2012
Condition(s): Diabetes Mellitus, Type 2; Kidney Disease
10
Completed
A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263
Last Updated: March 29, 2012
Condition(s): Diabetes Mellitus, Type 2
11
Completed
A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015)(COMPLETED)
Last Updated: January 14, 2012
Condition(s): Diabetes Mellitus, Type 2
12
Not yet recruiting
Pharmacogenetics of Ace Inhibitor-Associated Angioedema
Last Updated: August 25, 2011
Condition(s): Hypertension; Diabetes Type 2
13
Active, not recruiting
Bone Turnover in Type 2 Diabetes Patients
Last Updated: June 25, 2010
Condition(s): Type 2 Diabetes
14
Completed
Phase III Trial to Evaluate the Efficacy and Safety of LC15-0444 Compared With Sitagliptin Added to Ongoing Metformin Therapy in Patients With Type 2 Diabetes
Last Updated: May 17, 2012
Condition(s): Type 2 Diabetes Mellitus
15
Completed
Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059 AM1)
Last Updated: April 21, 2011
Condition(s): Type 2 Diabetes Mellitus (T2DM)
16
Completed
Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus
Last Updated: April 27, 2012
Condition(s): Diabetes, Type 2
17
Active, not recruiting
Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 Diabetes
Last Updated: May 14, 2012
Condition(s): Type 1 Diabetes
18
Completed
MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus
Last Updated: April 7, 2010
Condition(s): Type 2 Diabetes Mellitus
19
Not yet recruiting
A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253)
Last Updated: May 2, 2012
Condition(s): Type 2 Diabetes Mellitus
20
Not yet recruiting
A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254)
Last Updated: May 2, 2012
Condition(s): Type 2 Diabetes Mellitus

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Matching+placebo+to+sitagliptin

Page 1 of Clinical Trials for Drug Matching placebo to sitagliptin, 43 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About